AREV Negotiations to Acquire 50% of Lighthouse GenomicsAREV is still building. I am no expert in genomics so I don't know how much this will go in keeping AREV viable in all the competition. Of course it is not news that excites the market but hopefully at some point we will get news that does.
[url=https://www.stockwatch.com/News/Item.aspx?bid=Z-C%3aAREV-2808544&symbol=AREV®ion=C][/url]